trending Market Intelligence /marketintelligence/en/news-insights/trending/hWXktwtR4PpF0SDFuOxjDA2 content esgSubNav
In This List

Biostage to delist from Nasdaq

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Biostage to delist from Nasdaq

Biostage Inc. said Nasdaq will complete the delisting process for its common stock, after it failed to regain compliance with the rules.

The biotech company receive the notice of suspension in October. Concurrently, it started trading on the OTCQB marketplace under the symbol BSTG.

Biostage said the Nasdaq delisting will not affect its OTCQB marketplace listing.